These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 20601373
1. The protective effect of thalidomide on left ventricular function in a rat model of diabetic cardiomyopathy. Kim DH, Kim YJ, Chang SA, Lee HW, Kim HN, Kim HK, Chang HJ, Sohn DW, Park YB. Eur J Heart Fail; 2010 Oct; 12(10):1051-60. PubMed ID: 20601373 [Abstract] [Full Text] [Related]
2. Dexmedetomidine restores autophagy and cardiac dysfunction in rats with streptozotocin-induced diabetes mellitus. Oh JE, Jun JH, Hwang HJ, Shin EJ, Oh YJ, Choi YS. Acta Diabetol; 2019 Jan; 56(1):105-114. PubMed ID: 30206697 [Abstract] [Full Text] [Related]
3. Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus. Gimenes R, Gimenes C, Rosa CM, Xavier NP, Campos DHS, Fernandes AAH, Cezar MDM, Guirado GN, Pagan LU, Chaer ID, Fernandes DC, Laurindo FR, Cicogna AC, Okoshi MP, Okoshi K. Cardiovasc Diabetol; 2018 Jan 17; 17(1):15. PubMed ID: 29343259 [Abstract] [Full Text] [Related]
4. FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy. Zhang Y, Edgley AJ, Cox AJ, Powell AK, Wang B, Kompa AR, Stapleton DI, Zammit SC, Williams SJ, Krum H, Gilbert RE, Kelly DJ. Eur J Heart Fail; 2012 May 17; 14(5):549-62. PubMed ID: 22417655 [Abstract] [Full Text] [Related]
5. Mangiferin mitigates diabetic cardiomyopathy in streptozotocin-diabetic rats. Hou J, Zheng D, Zhong G, Hu Y. Can J Physiol Pharmacol; 2013 Sep 17; 91(9):759-63. PubMed ID: 23984905 [Abstract] [Full Text] [Related]
9. Usefulness of mitral annulus velocity for the early detection of left ventricular dysfunction in a rat model of diabetic cardiomyopathy. Kim DH, Kim YJ, Kim HK, Chang SA, Kim MS, Sohn DW, Oh BH, Park YB. J Cardiovasc Ultrasound; 2010 Mar 17; 18(1):6-11. PubMed ID: 20661329 [Abstract] [Full Text] [Related]
13. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo. Cao N, Wong YG, Rosli S, Kiriazis H, Huynh K, Qin C, Du XJ, Kemp-Harper BK, Ritchie RH. Circ Heart Fail; 2015 May 17; 8(3):572-81. PubMed ID: 25737497 [Abstract] [Full Text] [Related]
14. Rutin administration attenuates myocardial dysfunction in diabetic rats. Guimaraes JF, Muzio BP, Rosa CM, Nascimento AF, Sugizaki MM, Fernandes AA, Cicogna AC, Padovani CR, Okoshi MP, Okoshi K. Cardiovasc Diabetol; 2015 Jul 17; 14():90. PubMed ID: 26185015 [Abstract] [Full Text] [Related]
15. 1,25(OH)2 D3 improves cardiac dysfunction, hypertrophy, and fibrosis through PARP1/SIRT1/mTOR-related mechanisms in type 1 diabetes. Qu H, Lin K, Wang H, Wei H, Ji B, Yang Z, Peng C, Xiao X, Deng H. Mol Nutr Food Res; 2017 May 17; 61(5):. PubMed ID: 27561793 [Abstract] [Full Text] [Related]
18. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Westermann D, Van Linthout S, Dhayat S, Dhayat N, Schmidt A, Noutsias M, Song XY, Spillmann F, Riad A, Schultheiss HP, Tschöpe C. Basic Res Cardiol; 2007 Nov 17; 102(6):500-7. PubMed ID: 17909696 [Abstract] [Full Text] [Related]